BDMD

Baird Medical Investment Holdings Ltd Ordinary Share

1.83 USD
-0.50
21.46%
At close Dec 20, 4:00 PM EST
After hours
1.72
-0.11
6.01%
1 day
-21.46%
5 days
12.27%
1 month
-25.91%
3 months
-63.40%
6 months
-63.40%
Year to date
-63.40%
1 year
-63.40%
5 years
-63.40%
10 years
-63.40%
 

About: Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Research analyst outlook

We haven’t received any recent analyst ratings for BDMD.

Financial journalist opinion

Based on 4 articles about BDMD published over the past 30 days

Neutral
PRNewsWire
5 days ago
Baird Medical Sponsored and Participated in 2024 Guangdong Thyroid Surgery Committee Annual Meeting
NEW YORK , Dec. 17, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in minimally invasive medical technologies, proudly sponsored and participated in the 2024 Guangdong Thyroid Surgery Committee Annual Meeting in Guangdong, China. The forum, hosted by the Guangdong Provincial Hospital of Traditional Chinese Medicine, brought together experts to advance thyroid disease treatment.
Baird Medical Sponsored and Participated in 2024 Guangdong Thyroid Surgery Committee Annual Meeting
Neutral
PRNewsWire
6 days ago
Baird-Sponsored Microwave Ablation Training Advances Innovation in Thyroid Care
NEW YORK , Dec. 16, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology, recently sponsored another advanced MWA training session in New Orleans. The program provided hands-on experience with a cutting-edge treatment that offers patients faster recovery times and effective relief from thyroid nodules.
Baird-Sponsored Microwave Ablation Training Advances Innovation in Thyroid Care
Neutral
PRNewsWire
1 week ago
Baird Medical Charts 2025 Strategic Vision Following Milestone Year
NEW YORK , Dec. 10, 2024 /PRNewswire/ -- Baird Medical Group (NASDAQ: BDMD), a leader in minimally invasive medical technologies, recently convened its 2024 Annual Review and 2025 Planning Meeting at the Baird Capital Tower in Guangzhou, China. The two-day event brought together executives, production leaders, and regional managers to reflect on the company's achievements and plan for the year ahead.
Baird Medical Charts 2025 Strategic Vision Following Milestone Year
Neutral
PRNewsWire
3 weeks ago
Baird Medical Sponsored and Showcased Microwave Ablation (MWA) Technology at the 7th Thyroid Disease Forum in China
NEW YORK , Nov. 25, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a global leader in minimally invasive microwave ablation (MWA) technology, proudly sponsored and participated in the 2024 7th Thyroid Disease Standardized Diagnosis and Treatment Forum and Guangdong Pharmaceutical Society Thyroid Specialist Committee Annual Meeting, held in Guangzhou, China. This prestigious forum, hosted by the Guangdong Provincial People's Hospital and organized by leading medical and pharmaceutical associations in Guangdong, brought together top experts and healthcare professionals to advance standardized treatment protocols for thyroid diseases.
Baird Medical Sponsored and Showcased Microwave Ablation (MWA) Technology at the 7th Thyroid Disease Forum in China
Neutral
PRNewsWire
1 month ago
Baird Medical Showcased Microwave Ablation Technology at Massachusetts Society of Otolaryngology Event
NEW YORK , Nov. 11, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in microwave ablation technology, proudly participated in the recent Massachusetts Society of Otolaryngology (MSO) event. This year's event centered on emerging trends in Otolaryngology, with a focus on the increasing shift toward office-based surgical procedures.
Baird Medical Showcased Microwave Ablation Technology at Massachusetts Society of Otolaryngology Event
Neutral
PRNewsWire
1 month ago
Baird Medical's Advanced Microwave Ablation Solutions Captivate Attendees at the 2024 ATA Meeting
NEW YORK , Nov. 4, 2024 /PRNewswire/ -- Baird Medical (Nasdaq: BDMD), a leader in minimally invasive microwave ablation (MWA) technology, proudly participated in the 2024 American Thyroid Association (ATA) Annual Meeting. This year's event marked a milestone for Baird Medical, as it attracted significant interest from physicians and researchers worldwide, including attendees from the U.S., Europe, and South America.
Baird Medical's Advanced Microwave Ablation Solutions Captivate Attendees at the 2024 ATA Meeting
Neutral
PRNewsWire
1 month ago
Baird Medical Advances Global Academic Collaboration in Thyroid Health
NEW YORK , Oct. 28, 2024 /PRNewswire/ -- From October 24-27, Baird Medical proudly invited and gathered leading experts from the U.S. and China to advance the field of thyroid care through a series of impactful events, solidifying its role in the global academic and clinical exchange. On October 25, Baird hosted the Sixth Global Thyroid Microwave Ablation Technology Exchange Conference.
Baird Medical Advances Global Academic Collaboration in Thyroid Health
Neutral
PRNewsWire
1 month ago
Baird Medical Proudly Invited to Showcase Microwave Ablation Technology at the ACS Clinical Congress
NEW YORK , Oct. 24, 2024 /PRNewswire/ -- Baird Medical, (NASDAQ: BDMD) a global leader in minimally invasive microwave ablation (MWA) technology, successfully participated in the prestigious 2024 American College of Surgeons (ACS) Clinical Congress held at the renowned Moscone Center in San Francisco. This year's congress attracted over 10,000 attendees, including 7,000 surgeons from around the world, making it one of the largest surgical events globally.
Baird Medical Proudly Invited to Showcase Microwave Ablation Technology at the ACS Clinical Congress
Neutral
PRNewsWire
2 months ago
Baird Medical to Participate in the American Thyroid Association (ATA) Annual Meeting
NEW YORK , Oct. 14, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading developer and provider of microwave ablation ("MWA") medical devices in China, which recently expanded into the U.S. market following its U.S. FDA 510(k) clearances, today announced its participation in the upcoming American Thyroid Association (ATA) Annual Meeting.
Baird Medical to Participate in the American Thyroid Association (ATA) Annual Meeting
Neutral
PRNewsWire
2 months ago
Baird Medical Announces Preliminary Financial Results for the Six Months Ended June 30, 2024
Total revenues increased to US$13.1 million, representing 13.8% year-over-year growth Net income reached US$4.4 million, representing 85.8% year-over-year growth GUANGZHOU, China , Oct. 11, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced its preliminary financial results for the six months ended June 30, 2024 (the "First Half of 2024").
Baird Medical Announces Preliminary Financial Results for the Six Months Ended June 30, 2024
Charts implemented using Lightweight Charts™